Ordering Tagrisso (Osimertinib) from India: Huge Savings on AstraZeneca's Life-Saving Lung Cancer Drug

 

Tagrisso (generic name: osimertinib), a targeted therapy developed by AstraZeneca, has become a crucial treatment for patients with non-small cell lung cancer (NSCLC) that harbors specific mutations in the epidermal growth factor receptor (EGFR) gene.

While the drug has shown remarkable effectiveness in extending survival, the cost of treatment in the United States remains a significant financial burden for many patients.

Fortunately, Tagrisso is available from licensed suppliers in India, offering the same branded medication at a much lower cost—potentially saving patients tens of thousands of dollars over the course of treatment.

What is Tagrisso?

Tagrisso is an EGFR-TKI (tyrosine kinase inhibitor) used as a first-line treatment for patients with EGFR-mutated NSCLC and for those whose cancer has progressed after prior EGFR-TKI therapy.

It works by inhibiting the activity of mutated EGFR proteins, thereby slowing or stopping the growth of cancer cells.

Key Benefits of Tagrisso:

  • Targets both common EGFR mutations and the T790M resistance mutation
  • Prolongs progression-free and overall survival
  • Available in convenient oral tablet form

Common Side Effects of Tagrisso

While effective, Tagrisso can cause side effects. Some of the most commonly reported include:

  • Diarrhea
  • Rash
  • Dry skin
  • Nail inflammation
  • Fatigue
  • Decreased appetite

More serious side effects, though rare, can include lung inflammation, heart issues (QT prolongation), and eye problems.

Always consult your oncologist to monitor for adverse reactions.

Tagrisso Cost: U.S. vs. India

The price of Tagrisso in the United States can exceed $15,000 USD per month depending on pharmacy, insurance coverage, and location.

A full month’s treatment typically consists of 30 tablets.

In contrast, Tagrisso is available from India at a significantly reduced price. According to current market listings, one tablet of Tagrisso (80 mg) from India costs $416.67 USD.

That puts the monthly cost (30 tablets) at:

  • India: $12,500 USD
  • U.S.: $15,000 – $18,000 USD

Estimated Savings: Patients can save up to $5,500 USD or more per month by purchasing Tagrisso from India, which translates to over $66,000 USD annually.

How to Safely Buy Tagrisso from India

Tagrisso is a prescription-only medication. Patients interested in sourcing the drug from India must have a valid prescription and should work with a reputable international pharmacy that offers:

  • Verification of product authenticity
  • Doctor or prescription validation process
  • Cold-chain logistics if required

Before importing, always check with your country’s regulatory guidelines regarding the import of prescription drugs for personal use.

Conclusion

Tagrisso continues to be a breakthrough therapy for certain lung cancer patients, but its cost in the U.S. remains a barrier.

Accessing the drug through legitimate Indian pharmaceutical channels can offer significant savings without compromising on quality, as the medication is still manufactured by AstraZeneca.

For many patients and families, this price difference can mean the ability to afford continuous treatment without the crushing financial toll.

 

This article has been viewed 30 times.